PE20001414A1 - Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidad - Google Patents
Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidadInfo
- Publication number
- PE20001414A1 PE20001414A1 PE2000000005A PE0000052000A PE20001414A1 PE 20001414 A1 PE20001414 A1 PE 20001414A1 PE 2000000005 A PE2000000005 A PE 2000000005A PE 0000052000 A PE0000052000 A PE 0000052000A PE 20001414 A1 PE20001414 A1 PE 20001414A1
- Authority
- PE
- Peru
- Prior art keywords
- weight
- procedure
- average
- water solubility
- pharmaceutical substance
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 238000001033 granulometry Methods 0.000 abstract 2
- PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 abstract 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 abstract 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 abstract 1
- 229940120889 dipyrone Drugs 0.000 abstract 1
- 238000001125 extrusion Methods 0.000 abstract 1
- 210000004051 gastric juice Anatomy 0.000 abstract 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000004353 relayed correlation spectroscopy Methods 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 238000005563 spheronization Methods 0.000 abstract 1
- 229960003107 tramadol hydrochloride Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE GLOBULOS CARACTERIZADO POR UN CONTENIDO a)MAYOR DE 5O% EN PESO DE UNA SUSTANCIA ACTIVA TAL COMO CLORHIDRATO DE TRAMADOL, METAMIZOL SODICO, CLORHIDRATO DE DIFENHIDRAMINA CON UNA HIDROSOLUBILIDAD > 0.5 g/ml; b)COMO MAXIMO 50% EN PESO DE UNA COMBINACION DE i)UNA CELULOSA MICROCRISTALINA CON UNA GRANULOMETRIA PROMEDIO DE 15µm A 20µm, ii)HIDROXIPROPILCELULOSA DE BAJA SUSTITUCION CON UNA GRANULOMETRIA PROMEDIO DE 10µm A 25µm SIENDO LA RELACION PONDERAL DE SUSTANCIA ACTIVA A CELULOSA DE 4:6 HASTA 6:4; c)POR INCORPORARSE A LA MEZCLA UNA CANTIDAD DE AGUA INDISPENSABLE PARA OBTENER UNA PLASTICIDAD SUFICIENTE PARA LA EXTRUSION Y ESFERONIZACION. LOS GLOBULOS ESTAN PROVISTOS DE UN REVESTIMIENTO DE LIBERACION RETARDADA O UN REVESTIMIENTO RESISTENTE AL JUGO GASTRICO Y SON ENVASADOS EN CAPSULAS O COMPRIMIDOS EN FORMA DE TABLETAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19901692A DE19901692C2 (de) | 1999-01-18 | 1999-01-18 | Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001414A1 true PE20001414A1 (es) | 2000-12-23 |
Family
ID=7894569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000005A PE20001414A1 (es) | 1999-01-18 | 2000-01-04 | Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidad |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6558704B1 (es) |
| EP (1) | EP1020181A1 (es) |
| JP (1) | JP2000212068A (es) |
| KR (1) | KR20000076475A (es) |
| CN (1) | CN1161108C (es) |
| AU (1) | AU764280C (es) |
| CA (1) | CA2295470A1 (es) |
| CO (1) | CO4910118A1 (es) |
| CZ (1) | CZ291936B6 (es) |
| DE (1) | DE19901692C2 (es) |
| HU (1) | HUP0000141A3 (es) |
| IL (1) | IL134079A (es) |
| NZ (1) | NZ502264A (es) |
| PE (1) | PE20001414A1 (es) |
| PL (1) | PL337864A1 (es) |
| RU (1) | RU2221553C2 (es) |
| SK (1) | SK285423B6 (es) |
| ZA (1) | ZA200000169B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE279186T1 (de) * | 1999-08-31 | 2004-10-15 | Gruenenthal Gmbh | Retardierte darreichungsform enthaltend tramadolsaccharinat |
| FR2827771B1 (fr) * | 2001-07-25 | 2003-10-24 | Apis Spheromont | Formulation et procede de preparation de spheroides pouvant etre fortement titres et a dispersion rapide |
| US8128957B1 (en) | 2002-02-21 | 2012-03-06 | Valeant International (Barbados) Srl | Modified release compositions of at least one form of tramadol |
| US20050182056A9 (en) * | 2002-02-21 | 2005-08-18 | Seth Pawan | Modified release formulations of at least one form of tramadol |
| BR0312206A (pt) * | 2002-06-27 | 2005-04-12 | Cilag Ag | Formulações de pélete esférico |
| TW200404004A (en) * | 2002-09-09 | 2004-03-16 | Ss Pharmaceutical Co | Molded medicament for promotion of sleeping |
| KR100510270B1 (ko) * | 2002-11-29 | 2005-08-26 | 센츄론(주) | 펠렛타이저를 이용한 서방성 제제의 제조방법 |
| US9107804B2 (en) | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
| CA2529984C (en) * | 2003-06-26 | 2012-09-25 | Isa Odidi | Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
| US8394409B2 (en) * | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
| US20060024361A1 (en) * | 2004-07-28 | 2006-02-02 | Isa Odidi | Disintegrant assisted controlled release technology |
| US10624858B2 (en) * | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
| EP1629834A1 (en) † | 2004-08-27 | 2006-03-01 | KRKA, D.D., Novo Mesto | Sustained release pharmaceutical composition of tolterodine |
| US8221792B2 (en) * | 2005-07-07 | 2012-07-17 | Farnam Companies, Inc. | Sustained release pharmaceutical compositions for highly water soluble drugs |
| US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
| US20070190141A1 (en) * | 2006-02-16 | 2007-08-16 | Aaron Dely | Extended release opiate composition |
| EP2010162A4 (en) * | 2006-04-03 | 2013-01-09 | Isa Odidi | COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT |
| JP5457830B2 (ja) | 2006-04-03 | 2014-04-02 | オディディ，イサ | オルガノゾル被膜を含む制御放出送達デバイス |
| US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
| US7979151B2 (en) * | 2007-12-06 | 2011-07-12 | International Business Machines Corporation | Run-time dispatch system for enhanced product characterization capability |
| TWI400089B (zh) | 2009-11-24 | 2013-07-01 | Nippon Soda Co | 羥烷基纖維素微粒子 |
| DE102012007671A1 (de) | 2012-04-16 | 2013-10-17 | Acino Pharma Ag | Pellets mit hohem Wirkstoffgehalt |
| US10966928B2 (en) | 2016-03-25 | 2021-04-06 | Universiteit Gent | Oral dosage form |
| EP3432865B1 (en) | 2016-03-25 | 2021-05-19 | Universiteit Gent | Oral dosage form |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| WO2018087109A1 (de) | 2016-11-08 | 2018-05-17 | Grünenthal GmbH | Multipartikuläre arzneiform mit kontrollierter freisetzung von metamizol |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2581541B1 (fr) * | 1985-05-09 | 1988-05-20 | Rhone Poulenc Sante | Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation |
| GB9119052D0 (en) * | 1991-09-06 | 1991-10-23 | Boots Co Plc | Pharmaceutical compositions |
| US5234697A (en) * | 1992-06-22 | 1993-08-10 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
| RU2034533C1 (ru) * | 1993-02-25 | 1995-05-10 | Химико-фармацевтическое акционерное общество открытого типа "Октябрь" | Анальгезирующее жаропонижающее лекарственное средство и способ его получения |
| DE4329794C2 (de) * | 1993-09-03 | 1997-09-18 | Gruenenthal Gmbh | Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung |
| GB9422154D0 (en) | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
| DE19710008A1 (de) * | 1997-03-12 | 1998-09-17 | Basf Ag | Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung |
-
1999
- 1999-01-18 DE DE19901692A patent/DE19901692C2/de not_active Expired - Fee Related
- 1999-12-23 EP EP99125697A patent/EP1020181A1/de not_active Withdrawn
-
2000
- 2000-01-04 PE PE2000000005A patent/PE20001414A1/es not_active Application Discontinuation
- 2000-01-11 NZ NZ502264A patent/NZ502264A/en not_active IP Right Cessation
- 2000-01-14 CA CA002295470A patent/CA2295470A1/en not_active Abandoned
- 2000-01-17 CN CNB001045245A patent/CN1161108C/zh not_active Expired - Fee Related
- 2000-01-17 JP JP2000008280A patent/JP2000212068A/ja not_active Withdrawn
- 2000-01-17 HU HU0000141A patent/HUP0000141A3/hu unknown
- 2000-01-17 AU AU12442/00A patent/AU764280C/en not_active Ceased
- 2000-01-17 CO CO00002028A patent/CO4910118A1/es unknown
- 2000-01-17 ZA ZA200000169A patent/ZA200000169B/xx unknown
- 2000-01-17 PL PL00337864A patent/PL337864A1/xx not_active Application Discontinuation
- 2000-01-17 CZ CZ2000167A patent/CZ291936B6/cs not_active IP Right Cessation
- 2000-01-17 SK SK68-2000A patent/SK285423B6/sk not_active IP Right Cessation
- 2000-01-17 KR KR1020000002009A patent/KR20000076475A/ko not_active Abandoned
- 2000-01-17 RU RU2000101022/15A patent/RU2221553C2/ru not_active IP Right Cessation
- 2000-01-17 IL IL13407900A patent/IL134079A/en not_active IP Right Cessation
- 2000-01-18 US US09/484,015 patent/US6558704B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL134079A (en) | 2004-12-15 |
| HU0000141D0 (en) | 2000-03-28 |
| HUP0000141A2 (hu) | 2000-12-28 |
| CN1270025A (zh) | 2000-10-18 |
| CO4910118A1 (es) | 2000-04-24 |
| KR20000076475A (ko) | 2000-12-26 |
| DE19901692A1 (de) | 2000-07-20 |
| ZA200000169B (en) | 2000-08-07 |
| EP1020181A1 (de) | 2000-07-19 |
| DE19901692C2 (de) | 2002-06-20 |
| SK285423B6 (sk) | 2007-01-04 |
| NZ502264A (en) | 2001-11-30 |
| CZ2000167A3 (cs) | 2000-09-13 |
| SK682000A3 (en) | 2000-08-14 |
| CZ291936B6 (cs) | 2003-06-18 |
| HUP0000141A3 (en) | 2001-01-29 |
| AU764280B2 (en) | 2003-08-14 |
| PL337864A1 (en) | 2000-07-31 |
| JP2000212068A (ja) | 2000-08-02 |
| AU1244200A (en) | 2000-07-20 |
| IL134079A0 (en) | 2001-04-30 |
| RU2221553C2 (ru) | 2004-01-20 |
| US6558704B1 (en) | 2003-05-06 |
| AU764280C (en) | 2004-06-24 |
| CA2295470A1 (en) | 2000-07-18 |
| CN1161108C (zh) | 2004-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20001414A1 (es) | Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidad | |
| FI117042B (fi) | Oraalisesti annettavat farmaseuttiset formulaatiot | |
| WO2004012700A3 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
| BG66095B1 (bg) | Хидрофилен състав с контролирано освобождаване съдържащ прежелатинирано нишесте в препарат | |
| BRPI0015567B8 (pt) | composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica | |
| ES2331046T1 (es) | Formulacion de liberacion controlada. | |
| PE71699A1 (es) | Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra | |
| FI117373B (fi) | Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti | |
| IL161587A (en) | Pharmaceutical composition containing 3 - (3 - dimethylamino - 1 - ethyl - 2 - methyl - propyl) phenol and providing delayed release of the active ingredient | |
| CO5060477A1 (es) | Forma de dosificacion de nefazodona | |
| AR066313A2 (es) | Una formulacion de liberacion controlada de galantamina, una forma farmaceutica de dosificacion, un proceso para la preparacion de dicha formulacion, y el uso de dicha formulacion para la manufactura de un medicamento | |
| CO5160287A1 (es) | Formulacion de liberacion controlada de divalproex sodico | |
| AR028504A2 (es) | Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial | |
| CA2354057A1 (en) | Sustained release tablet containing hydrocolloid and cellulose ether | |
| HUE035834T2 (en) | Freeze-dried active ingredient composition | |
| ITRM20000667A1 (it) | Compressa matrice che permette la liberazione prolungata di trimetazidina dopo somministrazione per via orale. | |
| AU2431702A (en) | Process for preparing pharmaceutical compositions for use with soft gelatin formulations | |
| AR019899A1 (es) | Composicion farmaceutica y un procedimiento para prepararla. | |
| IL174830A0 (en) | Pellets containing venlafaxine hydrochloride, pharmaceutical compositions comprising them and processes for their preparation | |
| GR20010100377A (el) | Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη | |
| CO4700033A1 (es) | Preparados de liberacion controlada a base de una sal pota- sica alcalinizante | |
| UA89349C2 (uk) | Таблетка без покриття, яка містить оланзапін, та спосіб її одержання | |
| AR002972A1 (es) | Pildoras que tienen una matriz farmaceutica que proporcionan un perfil apropiado de liberacion de la droga, composicion para la preparacion de dichamatriz, proceso para preparar dichas pildoras y formas de dosificacion de dicha composicion. | |
| AR026451A1 (es) | Compuestos heterociclicos sililados | |
| AR001349A1 (es) | Nueva composición farmacéutica que contiene trimebutina y proceso para su preparación. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |